Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
3
50%
Ph phase_1
2
33%
Ph not_applicable
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(2)
Terminated(1)
Other(3)

Detailed Status

unknown3
Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 43 (50.0%)
N/A1 (16.7%)

Trials by Status

unknown350%
withdrawn117%
completed233%

Recent Activity

0 active trials
Showing 5 of 6
unknownnot_applicable

Clinical Study to Evaluate the Safety and Efficacy of New Probiotic Strains in Health Adults

NCT04758845
withdrawnphase_4

Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel

NCT02571283
unknownphase_4

Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty

NCT02592694
unknownphase_4

Cocktail Injection Improves Outcomes of FFR Guided PCI

NCT02592720
completedphase_1

Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects

NCT02045966
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04758845Not Applicable

Clinical Study to Evaluate the Safety and Efficacy of New Probiotic Strains in Health Adults

Unknown
NCT02571283Phase 4

Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel

Withdrawn
NCT02592694Phase 4

Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty

Unknown
NCT02592720Phase 4

Cocktail Injection Improves Outcomes of FFR Guided PCI

Unknown
NCT02045966Phase 1

Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects

Completed
NCT01570569Phase 1

Development of Minidose Inje Cocktail Method for Simultaneous Evaluating Five Cytochrome P450 Isoforms in Human

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6